The DOG recognised Heidelberg Engineering founder Christoph Schoess, Prof Herbert Kaufmann, and Prof Ioannis G. Pallikaris ...
AAO 2024: Centricity Vision to unveil new ZEPTOLink enhancements for improved efficiency and control
Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...
David Eichenbaum, MD and Riad Sherif, MD, CEO of Oculis will present the updates with additional info on topline results from ...
AD is a neurodegenerative disease characterized by neuronal loss in the cerebral cortex and the formation of extracellular ...
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over ...
Artificial intelligence has the potential to improve ophthalmology practices by streamlining documentation, enhancing ...
The phase 3 clinical trial is a randomized, double-blind, three-arm study comparing MELT-300, sublingual midazolam, and ...
On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and ...
Nanoscope plans to submit a BLA for MCO-010 in Q1 2025, following positive FDA feedback. MCO-010 is an optogenetic therapy for vision restoration in advanced retinitis pigmentosa, independent of gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback